Skip to search formSkip to main contentSkip to account menu

B 5833

Known as: B-5833, S-58-33, SB 5833 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Temazepamcamazepam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
S-58 大陸沿岸の海底下生命圏((8)「ちきゅう」による南海トラフ地震発生帯掘削計画ステージ1Aの成果[総括],口頭発表,シンポジウム)
2007
2007
Impact of genetic resistance to sugarbeet cyst nematode on yield and quality of sugarbeets
Sugarbeet Cyst Nematode can cause significant yield loss in many sugarbeet producing areas of the United States. Field trials… 
2006
2006
S-58 高分解能大気海洋結合モデルを用いた将来の温暖化に対する黒潮の変化について(招待講演,(7)黒潮システム変動と東アジアの気候変動-現在,過去,未来-,口頭発表,シンポジウム)
1975
1975
[Psychopharmacological agents and therapy of the climacteric: clinical study of camazepam (B 5833), a new psychopharmacological agent].
1974
1974
A preliminary double-blind study with SB 5833 (camazepam), a new benzodiazepine derivative.
1974
1974
[Clinical observations on the action of the new benzodiazepine, B 5833 (camazepm)].
1974
1974
[Double-blind trial treatment of anxiety with b 5833].
1974
1974
[Camazepam (B 5833) in therapy of angina pectoris].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)